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tices in patient evaluation and selection for minimally invasive mitral
valve procedures, and discusses preoperative planning for cannulation
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Patients' demand for minimally invasive cardiac procedures hasrisen dramatically since the Heartport platform was first devel-
oped in 1996.1 Although early outcomes in coronary artery bypass
grafting with this platform were less than desirable owing to steep
learning curves,1–3 use of minimally invasive approaches for
valve surgery has increased.4–10 Today, minimally invasive ap-
proaches to mitral valve repair and replacement (MIMVR) have
become preferred at numerous centers owing to less postopera-
tive bleeding and atrial fibrillation, a reduced incidence of
wound infection, and shorter hospital stays, quicker recovery, and
improved cosmesis.11–16 Nevertheless, MIMVR's benefits are not
accepted universally, and many surgeons remain apprehensive
about developing a MIMVR program owing to learning curves
and potential complications.See accompanying editorial on page 233, and articles on
pages 251 and 260Recognizing this knowledge and practice gap, a group of
26 experienced MIMVR surgeons convened to develop consen-
sus guidance aimed at facilitating adoption of MIMVR. This re-
port is the collaborative effort of these surgeons who collectively
have performed approximately 17,000 MIMVR procedures.
This work is the first of a 3-part series and details considerations
for patient evaluation and selection, as well as preoperative plan-
ning for successful cannulation, systemic perfusion, myocardial
protection, and anesthetic preparation. The second report focuses
on intraoperative techniques to performMIMVRwhileminimizing
complications,17 and the third manuscript describes considerations
specific to robotic-assisted MIMVR, as well as training pathways
that will prepare a surgical team to move from sternotomy to port
access to robotic approaches.18
The recommendations in these 3 reports are presented to
provide a framework to the new user ofMIMVR. They are based
on the 4 fundamental tenets of any cardiac operation including:243
thoracic Surgery. Unauthorized reproduction of this article is prohibited.
TABLE 2. Comorbidities of Concern for MIMVR Patient Selection
Comorbidity Potential Complication
Morbid obesity Compromised exposure
Significant lung disease Postoperative respiratory failure
Peripheral vascular disease Malperfusion and possible arterial injury
Advanced renal dysfunction Postoperative renal failure
Advanced liver disease Postoperative hepatic failure
Previous right thoracotomy Compromised exposure; lung injury
Significant pulmonary hypertension Inadequate postoperative RV function
Severe LV dysfunction Inadequate postoperative LV function
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C(1) establishment and maintenance of adequate cannulation and
perfusion, (2) complete myocardial protection, (3) optimal expo-
sure, and (4) procedures appropriate to the patient's specific pa-
thology.19 As in conventional mitral valve surgery, none of these
tenets should ever be compromised when considering less inva-
sive approaches.
PATIENT SCREENING
When starting an MIMVR program, all patients with iso-
lated MV disease should be considered candidates for MIMVR
until proven otherwise. There are, however, a number of comor-
bidities and anatomical considerations that should be viewed as
relative contraindications (Table 1). With increasing surgical
MIMVR experience, select patients with these high-risk comor-
bidities may be considered as well. Ultimately, the goal is to pro-
vide a safe, reliable, and reproducible operation with similar or
better outcomes than with median sternotomy. Evaluation ofTABLE 1. Relative Contraindications to MIMVR
Significant aortic, iliac, or femoral disease that prevents safe retrograde arterial
perfusion
Left ventricular ejection fraction < 25%
Severe right ventricular dysfunction
Pulmonary artery pressure > 70 mm Hg
Aorta > 4 cm if endoaortic balloon being used
Significant mitral annular calcification
Patients with more than mild aortic regurgitation
Kyphoscoliosis and pectus excavatum
Morbidly obese and extremely muscular patients
244 Copyright © 2016 by th
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for relevant comorbidities, examination for body habitus, and a
series of screening tests including computed tomography (CT)
angiography, echocardiography, as well as pulmonary function
testing and cardiac catheterization or coronary CTwhen indicated.
The ideal patient to begin MIMVR is one who requires an
isolated MV procedure (repair or replacement). Once a surgeon
gains experience, concurrent procedures such as tricuspid valve
orMaze procedures can also be performed through a port-access
incision. Hybrid approaches with percutaneous coronary inter-
vention and port-access MV surgery may be an option for select
patients, but pose additional considerations such as the order in
which the 2 procedures would be performed and initiation and
cessation of platelet inhibitors.
Comorbidities
The presence of some comorbidities makes certain patients
less-than-ideal candidates for MIMVR for different reasons
(Table 2), especially in a program's early experience when car-
diopulmonary bypass (CPB) times will likely trend longer.
Age itself should not be considered a contraindication, as
elderly, frail patients may benefit most fromMIMVR approaches.
Patients with previous stroke and difficulty with mobility may
also derive significant benefit from avoiding sternotomy. Careful
assessment of vasculature should be undertaken in both of these
populations, since they often have higher calcium burden.
Physical Examination and Body Habitus
The regional anatomy of the right chest and overall body
habitus must be evaluated (Table 3). One should examine the
right chest to determine whether the rib intercostal spaces
are palpable, and chest CT is helpful in assessing both bodyTABLE 3. Anatomic Considerations for MIMVR Patient Selection
Anatomic Feature Considerations
Heart Size and location
Aortic root,
ascending
aorta, and arch
Anatomy and extent of calcification; aneurysm;
dissection; diameter for occlusion approaches
Mitral annulus Calcification
Chest anatomy Distance to MV; obesity; muscularity; pectus excavatum;
prior rib fracture; high right diaphragm; scoliosis;
presence and location of breast implants
Lungs Location of the pulmonary hilum in relation to planned
working incision
e International Society for Minimally Invasive Cardiothoracic Surgery
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Cfat distribution and muscularity. Significantly, obese or muscu-
lar patients with thick chest walls can be challenging owing to
the added distance to the MV. Extremely muscular soft tissues
are difficult to compress, making exposure through the right-
chest working port challenging.
There are several considerations for female patients. Dur-
ing examination, consideration should be given to the location
and extent of the incisions relative to the breast. The incisions
can be made at the inframammary fold or lateral to the breast
to avoid subsequent bra irritation. Women with breast implants
should be assessed preoperatively to ensure that the appropriate
intercostal space for the working port can be used, that the left-
atrial roof retraction post can be placedmedially without damag-
ing the implant, and to identify compromised implant integrity.
In certain cases, the implant may be removed and then replaced
after the MVR is performed. At the time of operation, the right
breast should be retracted toward the left shoulder and held in
place with an adhesive sterile plastic drape.
Patients with prior chest trauma, chest tubes, history of
pneumothorax, or surgery to the right chest typically have adhe-
sions that can add time and morbidity to the operation. The sur-
geon must weigh the benefit of MIMVR against the risk of
added operative time and potential for pulmonary injury. In such
cases, it may be prudent to perform a thoracoscopy through a
5-mm camera port to determine if a right chest approach is safe.
If dense adhesions are encountered, another route is advisable.
Anatomic considerations include patients with kyphoscoliosis
or pectus excavatum, which can compromise exposure. In these
deformities, cardiac migration into the left chest occurs, limiting
working angles between the sternum and the spine and making ex-
posure difficult. This results in limited ability to lift the atrial septum
and creates additional distance between the incision and the heart.
Finally, if contemplating femoral cannulation, the surgeon
should evaluate the groins for suitable access, including palpable
arterial pulses, evidence of inguinal or femoral hernia (or history
of repaired hernia), large pannus, or concern for fungal infiltration
of the groin.
Echocardiography
Thorough assessment of MVand other cardiac pathologies
is necessary for safe patient selection (Table 4). A high-quality
transthoracic echocardiogram may diagnose the mechanism
of MV disease, but if it remains unclear, a preoperativeTABLE 4. Important Echocardiographic Findings DuringMIMVR
Patient Selection
Location Notable Echocardiographic Findings
Mitral valve Lesions and etiology of MV disease; risk factors for systolic
anterior motion; extent of annular calcification; presence
of rheumatic disease
Tricuspid valve Insufficiency; stenosis
Aortic valve Insufficiency; stenosis
Left and right
ventricles
End diastolic dimensions, ejection fraction < 25%
Pulmonary artery Pulmonary hypertension (systolic pressures > 70 mm Hg)
Coronary sinus Enlargement may be associated with a persistent left SVC
Aorta Atheroma
Copyright © 2016 by the International Society for Minimally Invasive Card
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initial cases for MIMVR include patients who require a sim-
ple annuloplasty, a focal posterior leaflet prolapse, or MV
replacement.
Mitral valve pathologies that are less amenable to port-access
MV surgery include significant mitral annular calcification in
which extensive debridement may be necessary, or those that
require extremely complex repair (eg, for rheumatic MV dis-
ease). Mitral annular calcification significantly increases the
risk of atrioventricular disruption, and annular decalcification
and subsequent suture placement can be difficult with single-
shaft instruments. Thus, preventive complex repair techniques
may need to be used to prevent this lethal complication. In these
most complicated MV operations, the surgeon's experience
should dictate the approach.
Patients with more than mild aortic valve insufficiency
should be approached with caution through the right chest, as ar-
resting, protecting, and decompressing the heart may be challeng-
ing. Greater consideration should be given to placing a retrograde
cardioplegia cannula, either directly through the right atrium or
through the right internal jugular (IJ) vein.
Since ischemic times are usually longer in right chest ap-
proaches, caution is advised in patients with an extremely low
left ventricular (LV) ejection fraction (<25%); particularly if
there is any concern that temporary left ventricular assist device
support may be required postoperatively. Patients with signifi-
cant right ventricular (RV) dysfunction or systolic pulmonary ar-
tery pressures greater than 70 mm Hg are known to have a
higher risk of mortality with surgery despite their STS risk.21
There is a concern that the RV is not as well protected in the right
chest approach since the RV cannot be topically cooled, al-
though this can be mitigated by using lower systemic perfusate
temperatures and more frequent redosing of cardioplegia. In
any MIMVR candidate with RV dysfunction or severe pulmo-
nary hypertension, optimal venous drainage is of even more im-
portance to preserve RV function upon separation from CPB.
Finally, echocardiography should be used to assess
aortic atheroma in conjunction with the chest CT, as signifi-
cant atheroma increases stroke risk and MIMVR is not ideal
in this setting.
Computed Tomographic Imaging of the Chest
In recent years, CT angiography (CTA) has become rou-
tine in evaluating patients for minimally invasive valve sur-
gery.19 There are a number of factors to evaluate on the chest
CT (Table 5). Since aortic occlusion is accomplished with either
an external cross-clamp or an internal endoaortic balloon, as-
cending aortic disease must be ruled out by CT. Complete occlu-
sion with the endoaortic balloon becomes less consistent in
aortas greater than 4 cm in diameter. Computed tomography is
also necessary to detect significant MV annular calcification,
which is a relative contraindication for MIMVR for inexperi-
enced surgeons.
The fourth intercostal space is most commonly used for
the working port; however, CT may help guide the surgeon
above or below this space to be in line with the pulmonary hilum.
Other anatomic abnormalities such as deformations in the chest
wall, ribs, or diaphragm should be evaluated for their potential
to complicate the surgical approach.iothoracic Surgery 245
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TABLE 5. Useful CTA Findings During MIMVR Patient Evaluation
Finding Considerations
Aorta Evaluate degree, location, and type of atheroma, including hard vs soft plaque; measure diameter of ascending
aorta (must be < 4 cm for endoaortic balloon)
Great vessels Rule out aberrant anatomy, including patent ductus arteriosus, persistent left SVC, and
aberrant right subclavian artery, which may make monitoring of an endoaortic balloon difficult
Mitral valve Evaluate degree of mitral annular calcification
Iliac artery Rule out aneurysm, tortuosity, plaque, and localized dissection or pseudoaneurysm from previous catheterization site
Common femoral and superficial femoral artery Identify bifurcation and location for site choice; measure common femoral artery diameter for cannulation
Venous anatomy Rule out venous anomalies or IVC filter
Ailawadi et al Innovations • Volume 11, Number 4, July/August 2016
CCT Imaging of the Aortoiliofemoral Vasculature
Although MIMVR can be performed with central can-
nulation techniques, most surgeons prefer peripheral cannu-
lation to minimize the chest incision and rib spreading, and
to provide uncluttered access to the MV. Planning for this
approach requires thorough knowledge of the peripheral
vascular anatomy.
Computed tomographic angiography (CTA) of the chest,
abdomen, and pelvis, preferably with contrast, provides the most
useful anatomic information. Computed tomographic without
contrast is still helpful but may not reveal subtleties in soft
plaque, an important consideration for peripheral cannulation
and retrograde arterial perfusion. The femoral and iliac arteries
and aorta should have minimal calcium, thrombus, or aneurys-
mal disease when planning femoral arterial access. Evidence
of an iliac or femoral artery dissection is a contraindication for
ipsilateral peripheral arterial cannulation. Patients with a history
of peripheral vascular disease should undergo evaluation with
lower extremity noninvasive studies and/or lower extremity
CTA, as cannulation can result in lower-extremity ischemia while
on CPB.
The venous anatomy should also be assessed. Although it
is unusual that femoral venous access cannot be used, patients
with a history of deep vein thrombosis, and particularly those
with an inferior vena cava (IVC) filter, may require a CT
venogram to ensure the IVC is patent.
Other Preoperative Testing
American Heart Association guidelines for left heart
catheterization include male patients older than 40 and post-
menopausal women undergoing valvular surgery.20 Radial ar-
tery access for cardiac catheterization is preferred to preserve
a virgin operative field and avoid local dissection of the fem-
oral arteries before port-access surgery. In patients who have a
low likelihood of disease or in young patients, one should
consider coronary CTA. Other conventional tests include ca-
rotid artery duplex scan and pulmonary function testing as
necessary. In young patients, assessment of the coronary artery
is not necessary but can still be helpful to assess dominance
and ability to protect the RV as well as the proximity and size
of the circumflex artery relative to the MV annulus. In cases
with significant LV or RV dysfunction, or significantly ele-
vated pulmonary artery pressures are suggested by echocardio-
gram, consideration for catheterization of the right side of the
heart should be given.246 Copyright © 2016 by th
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Although the principles and conduct of the operation have
similarities to a sternal approach, there is a greater reliance on
perfusion and anesthesia to perform MIMVR. When using a
transthoracic cross-clamp, a radial arterial line is often sufficient.
However, when using an endoaortic balloon, bilateral radial or
brachial arterial monitoring is necessary to ensure proper posi-
tioning of the device in the ascending aorta. Alternatives also in-
clude use of right radial and femoral arterial monitoring.
Since access to theMV is through the right chest, a double
lumen endotracheal tube (or a single lumen with bronchial blocker
for an experienced anesthesiologist) is preferable, as it is not un-
common to inflate and deflate the right lung while de-airing and
assessing for bleeding after CPB. This is especially true early in
one's experience.
After insertion of the TEE, a thorough inspection of the
MVand for any concomitant disease should be performed before
proceeding with MIMVR. One concern that has limited adoption
of MIMVR for many programs is the challenge of placing a ret-
rograde cardioplegia cannula into the coronary sinus. As previ-
ously noted, there are several options including avoidance of its
use, placement directly through the working port, or preoperative
transjugular coronary sinus cannulation. In the latter scenario,
the anesthesiologist places the cannula at the time of central line
insertion through the right IJ vein into the coronary sinus with
echocardiographic and fluoroscopic guidance. In addition, a pul-
monary artery vent can be placed percutaneously, which canmon-
itor the pulmonary artery pressures and function as a vent.
Other adjuncts to consider include cerebral and lower ex-
tremity oximetry to aid in identification of hypoperfusion to the
brain and in diagnosis of leg ischemia from peripheral cannula-
tion, respectively.22 Monitoring of the lower extremities with
near-infrared oximetry can allow for instantaneous comparisons
of blood flow between the cannulated and non-cannulated ex-
tremity. If comparison to the contralateral leg shows a significant
difference, a small cannula should be placed in the distal super-
ficial femoral artery to avoid leg ischemia.17
CANNULATION AND PERFUSION
CONSIDERATIONS
Because MIMVR affords less ability to visualize the
whole heart, a well thought out plan for cannulation, perfusion,
and myocardial protection should be made before going to the
operating room (Fig. 1). The goals of cannulation and perfusion
are to (1) provide complete drainage to the heart, (2) providee International Society for Minimally Invasive Cardiothoracic Surgery
thoracic Surgery. Unauthorized reproduction of this article is prohibited.
FIGURE 1. Placement of perfusion catheters and cannulas in minimally invasive mitral valve repair and replacement. A, Pulmonary
artery vent catheter. B, Coronary sinus catheter. C, Femoral venous cannula. D, Femoral arterial cannula. E, Endoaortic balloon occlusion
catheter.
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Cadequate systemic perfusion, (3) minimize risks of malperfusion
or vascular injury, and (4) minimize added time and cost.
Arterial Cannulation
As previously noted, CTA is essential in choosing arterial
access. Arterial perfusion for minimally invasive cardiac surgery
is generally done via the larger, less diseased common femoral
artery. The adequacy of femoral artery size can be anticipated
by CTA measurement. A 23-F side-arm arterial cannula should
be used if the femoral artery size will allow; if a 21-F side-arm
cannula is used, a higher arterial line pressure should be antici-
pated. If the femoral arteries are too small to accommodate a
21 F and if an endoaortic balloon is to be used, then a 19-F can-
nula can be placed in each femoral artery for perfusion and for
the endoaortic balloon; alternatively, to avoid bilateral femoral
artery cannulation, the transthoracic aortic cross-clamp can be
used. In situations where the vessel is not diseased but is small,
a graft can be sewn on the femoral artery in an end-to-side fash-
ion and cannulated to minimize risk of lower-extremity ische-
mia. In all circumstances, CPB should be initiated slowly to
prevent arterial spasm. The descending thoracic aorta should
be visualized by TEE as cardiopulmonary bypass is initiated in
the rare likelihood a false lumen is being created.
When the femoral system is not suitable for arterial inflow,
right or left axillary artery cannulation can be performed. Some
surgeons prefer central arterial cannulation as one report has
suggested a higher stroke rate with femoral cannulation,23 al-
though arterial cannulas can be challenging to insert or cannula-
tion sites difficult to repair through small incisions. Exposure ofCopyright © 2016 by the International Society for Minimally Invasive Card
opyright © 2016 by the International Society for Minimally Invasive Cardiothe ascending aorta for cannulation can be performed through
the working port or may require an additional incision, usually
right parasternal in the second or third intercostal space. This
can either be combined with direct clamping or with a specialized
cannula with balloon occlusion capabilities.
Venous Cannulation
Without adequate venous drainage, MIMVR becomes
significantly more challenging. Visualization can be difficult
with greater left heart return, and myocardial protection is less
than optimal. Venous drainage routinely uses a multistage fem-
oral venous catheter, typically placed from the right femoral vein
with advancement and final positioning in the superior vena
cava (SVC) under TEE guidance. The right femoral vein is gener-
ally preferred over the left owing to the more favorable relation-
ship with the iliac artery, where compression from that structure
on the left may impede passage. In patients with an IVC filter,
the femoral venous cannula can be passed through the filter, but
this may require fluoroscopic guidance. An alternative is to ad-
vance the femoral venous cannula to the filter and percutaneously
place a 15-F to 18-F femoral arterial cannula through the IJ vein
into the SVC.
Some centers routinely place a second venous line (15 F to
18 F) positioned into the SVC to aid in venous drainage. This
can be done from a low right jugular approach and completed
either by the anesthesiology team or by the surgeon using a
small previously placed catheter that has been prepped into the
surgical field. In this case, the femoral venous cannulawould only
be advanced to the IVC right atrial junction. In patientsiothoracic Surgery 247
thoracic Surgery. Unauthorized reproduction of this article is prohibited.
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Cundergoing transthoracic cross-clamping, rarely a patient will
need bicaval cannulation in situations where venous drainage
is inadequate with a single femoral venous cannula or expo-
sure of the valve is compromised. Two venous lines may alle-
viate concern about affecting drainage caused by left atrial
retraction, but a single venous cannula with correct placement
and vacuum assistance is often sufficient. Another adjunct that
can help with drainage is the use of the percutaneous pulmonary
arterial (PA) vent. This can be placed through the right jugular
vein by the anesthesiologist.
In all cases, consideration should be given to patient size
when deciding on single or double venous cannulation as well
as the use of a pulmonary artery vent. The surgeonmust be flexible
during the conduct of the operation to achieve the end goal of ade-
quate drainage, and must be willing to place a second venous line
to achieve this goal, either through the SVC or through the right
atrium proper.
MYOCARDIAL PROTECTION AND
AORTIC OCCLUSION
Since most MIMVR procedures are done with peripheral
cannulation, the strategies for myocardial protection and aortic
occlusion are different from those of sternotomy, although the
goals remain the same (Table 6).
Ventricular Fibrillation
The simplest option for myocardial protection is to avoid
aortic occlusion and cardioplegic arrest by using either ventric-
ular fibrillation or a beating heart strategy. The technique of
ventricular fibrillation for MV surgery presents potential disad-
vantages; and therefore, many MIMVR surgeons do not use
ventricular fibrillation as their standard myocardial protection
strategy for most cases. A large series has suggested a higher
perioperative stroke rate compared to aortic occlusion and
cardioplegic arrest.24 Higher stroke rates may be due to a num-
ber of factors, including the common practice of using “pump-
off ” periods to place anterior sutures; or to entraining air into
the LV with no ability to capture any air that is pushed into
the ascending aorta. Although this may be mitigated by the rou-
tine use of CO2 in the chest, inadequate de-airing may explain
worse outcomes with this approach. Moreover, ventricularTABLE 6. Comparison of Transthoracic Cross-Clamping, Endoaortic
Consideration Transthoracic Cross-Clampi
Effective aortic occlusion Always
Operative field encroachment and venous
drainage impairment
Occasional
Use in redo operations Difficult
Mitral valve exposure Optimal
Risk of aortic injury Possible adventitial hematom
Other cardiac structure injury Possible to pulmonary artery, left atrial
dome of left atrium
De-airing and stroke Adequate de-airing
Surgeon learning curve Moderate
Cost +
248 Copyright © 2016 by th
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of aortic insufficiency, which obscures the surgical field with
blood. Finally, atrial retraction may render the aortic valve in-
competent and result in excessive aortic insufficiency with
blood return into the LV; this can be especially challenging
when trying to place sutures in the left trigone. There are cer-
tain settings such as previous cardiac surgery with patent grafts
or previous aortic valve replacement in which ventricular fi-
brillation may be preferred,25,26 and the principles and strate-
gies of this technique should be appreciated by the MIMVR
surgeon; however, it is not recommended by these authors as
a standard choice for MIMVR surgery.
Cardioplegia-Based Strategies
When using cardioplegia, the surgical team should preoper-
atively plan an antegrade approach alone or a combined antegrade
and retrograde approach. This strategy can mirror the team's
customary approach and comfort level during conventional
sternotomy approaches to MV surgery. Although limited, grow-
ing experience with del Nido cardioplegia or crystalloid
histidine-tryptophan-ketoglutarate cardioplegia solutions sug-
gest that they require less frequent dosing and may reduce the
need for placement of retrograde cardioplegia. Any degree greater
than mild aortic valve regurgitation should prompt a consider-
ation for the use of retrograde cardioplegia.
Antegrade cardioplegia can be delivered by 2 approaches.
The first is by way of the aortic root through an externally
inserted cardioplegia needle. This is typically brought out
through the working port but can be placed through a separate
small incision in the right chest. In this scenario, a transthoracic
cross-clamp is required. The alternative is to use an endoaortic
balloon to occlude the aorta internally. With this technique,
antegrade cardioplegia is delivered through the endoaortic
balloon to the aortic root. If the endoaortic balloon is used
for antegrade cardioplegia delivery, higher line pressures and
longer infusion times should be anticipated given the length
of the catheter. The use of an endoaortic balloon requires ad-
ditional skill of the surgical team, including the perfusionist.
If retrograde cardioplegia is planned, there are 2 main
options for insertion. One is through the right atrium into the
coronary sinus; the other uses percutaneous coronary sinusBalloon Occlusion, and Ventricular Fibrillation
ng Endoaortic Balloon Ventricular Fibrillation
May migrate to arch vessels No occlusion
None None
Ideal Applicable
Optimal Suboptimal; especially with
aortic regurgitation
a Possible aortic dissection (?) None
appendage, None None
Adequate de-airing Increased risk for air embolism
and stroke
Increased Short
+++ None
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Ccannulation through the right IJ vein (see section on "Anesthe-
sia and Monitoring").
Aortic Occlusion
Aortic occlusion can be achieved with a transthoracic
cross-clamp or through endoaortic balloon occlusion. Early in
experience, most MIMVR surgeons begin with transthoracic
cross-clamping, as this is a familiar technique that allows direct
clamping of the aorta as one would typically do through a
sternotomy. The clamps are reusable and reproducible, and the
technique is inexpensive to use. The transthoracic cross-clamp
is placed through an entry site in the chest wall, anterior to the
SVC. There is potential for obstruction of upper-body venous
drainage from the cross-clamp, but this can be avoided by either
bicaval cannulation or proper position of a single venous femo-
ral cannula above the site where the cross-clamp crosses anterior
to the SVC.
The alternative to the transthoracic cross-clamp is endoaortic
balloon occlusion. Advantages of this technique include the ab-
sence of a cardioplegia hole in the ascending aorta and its poten-
tial problems. Because cardioplegia delivery and root venting
are performed through the catheter itself, there is no need for a
separate antegrade cardioplegia root catheter. This eliminates
any issues with suturing the aorta or bleeding from the puncture
site, and minimizes clutter in the operative field. Other advan-
tages are that it is inserted into the ascending aorta before initi-
ating CPB and can actually shorten pump and clamp times. It is
also ideal for use in redo operations.
Disadvantages of endoaortic balloon occlusion include
the need to place the catheter through the arterial cannula,
hence reducing the effective size of the arterial cannula. If this
results in excessively high line pressures or inadequate flow,
then the option exists to place the balloon through a separate
arterial cannulation site. Distal balloon migration resulting in
innominate artery occlusion has been observed, as has proxi-
mal migration with the potential to obscure the operative field,
especially the left fibrous trigone. Distal balloon migration
can be easily recognized by monitoring bilateral radial artery
pressures, and the potential for migration can be mitigated
by proper positioning. Early use of the endoaortic balloon raised
concerns of its association with aortic dissection, but this oc-
curred in an era before routine CTA use and awareness of
the importance of imagining when considering retrograde ar-
terial perfusion. Other disadvantages include the cost of the
catheter itself, the need for bilateral arterial lines to monitor
placement, and possible balloon puncture or rupture during
the procedure.
There are limited and exclusively retrospective data compar-
ing transthoracic cross-clamping and endoaortic balloon occlusion.
From the available data, there is no significant difference in
safety profiles between the 2 techniques. Both techniques have
a significantly lower stroke rate than ventricular fibrillation.
There is no difference in retrograde aortic dissection, bleeding,
or adequacy of myocardial protection.24,27,28
DISCUSSION AND CONCLUSION
It is noteworthy that the International Society forMinimally
Invasive Cardiothoracic Surgery (ISMICS) published a consensus
statement in 2010 that listed the following limitations to MIMVRCopyright © 2016 by the International Society for Minimally Invasive Card
opyright © 2016 by the International Society for Minimally Invasive Cardioversus open mitral repair: increased risk of stroke, increased risk
of aortic dissection, phrenic nerve palsy, groin complications,
and prolonged cross-clamp times.11 As noted in the statement,
the data upon which these observations were made are almost en-
tirely based on observational studies and not randomized prospec-
tive studies. It remains true today that there are no randomized
prospective studies to definitively address these issues. The
ISMICS statement was based on literature published before
March 2010 and, by their own statement, included only “retro-
spective studies with important differences in baseline patient
characteristics.” However, a few observations can be made. Use
of CTA for preoperative planning was used only uncommonly
by most MIMVR surgeons in the period before 2010. This might
explain the observed increased incidence of stroke and aortic dis-
section; the authors went into great detail concerning the use of
CTA for preoperative planning to avoid these complications.
Most MIMVR surgeons today are well aware of the possibility
of phrenic nerve palsy and have taken steps to avoid its occurrence.
With increasing experience, groin complications (lymphocele, arte-
rial complications, infection) have become exceedingly rare.
Whereas MIMVR increases cross-clamp time, the ISMICS con-
sensus statement did not show an increased mortality when
compared to open mitral repair.
In summary, selection of ideal patients and a well-
developed preoperative plan involving the operating room team,
the anesthesiologists, perfusionists, and surgeons are necessary
to a successful MIMVR program. It is imperative that the team
is comfortable with conventional MV surgery, including tech-
niques for repair through a sternotomy, before embarking on
MIMVR; and all teammembers must have a thorough understanding
of the procedure, its potential pitfalls, and complications. If the 4
inviolate principles of safe and reproducible cardiac surgery as
described in this paper are rigorously adhered to, then the
chances of program success will be greatly increased.
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